CA-FORTANIX-INC
10.10.2023 09:01:32 CEST | Business Wire | Press release
Fortanix® Inc., the data security company and pioneer of Confidential Computing, today announced new capabilities for Fortanix Data Security Manager (DSM) to help public and private organizations address growing data sovereignty requirements globally. Available now, the existing and new features deliver several key capabilities, including support for sovereign cloud, storing keys in sovereign boundaries, anonymization of private data, centralized control to manage access and enforce consistent policies across hybrid and multicloud environments, and more, all delivered via an intuitive user experience.
Organizations around the globe are taking urgent steps to meet strict, complex, and changing data sovereignty regulations. According to a Gartner® report, “Particularly in Europe, but also in other regions, governments are becoming increasingly concerned due to tightening privacy and data protection regulations impacting data sovereignty, data control, technological sovereignty and their dependence on foreign cloud infrastructure providers.”*
Complying with multitude of mandates is a major challenge for organizations, but Fortanix makes it easy for them to ensure compliance over sensitive data, while also bolstering security. The Fortanix flagship DSM offering can be provisioned within customers’ sovereign regions, enabling them to have a dedicated solution that meets regulations in their legislative jurisdictions.
“Data sovereignty goes beyond just where data resides; it is a multi-layered approach that encompasses data security, protection, and privacy. Fortanix’s existing and new capabilities exemplify our commitment to expanding and enhancing DSM to deliver the most advanced data security and privacy solution to organizations around the globe,” said Faiyaz Shahpurwala, chief product and strategy officer at Fortanix. “Security and data teams can now maintain greater international and cross-border security, compliance, and control over their data with a unified platform that is powered by confidential computing and validated by the highest industry certifications.”
“Data sovereignty, data privacy and compliance with regulations such as GDPR and Schrems II are an integral part of our work in behavioral research,” said Raj Jagesar, project lead for the Digital Phenotyping Research Program (Behapp) at the University of Groningen in the Netherlands. “With Fortanix DSM's External Key Manager for Google Cloud, we have full control over our encryption keys not just for compliance purposes, but also to mitigate any security risks related to sensitive personal data.”
Fortanix DSM’s key data sovereignty capabilities include:
- Full control over key generation and lifecycle management for hybrid, multicloud environments with natively integrated KMS and FIPS 140-2 Level 3 HSM
- The ability to store encryption keys separate from data and within sovereign regions
- Enforced least privileged data access with RBAC and Quorum Controls to support Zero Trust architecture
- Crypto agility with rapid migration to latest approved quantum-proof cryptographic algorithms
- Format-preserving encryption to anonymize sensitive data at ingestion or creation before sharing across pipelines and workflows to keep it private, usable, and compliant
- Native database encryption to manage and store the keys required to encrypt all databases, including Oracle, SQL Server, MongoDB, PostGres, MySQL, Maria DB, IBM DB2, and more
- Joint VMware and Fortanix solution for scalable data protection and compliance for VMware Sovereign cloud environments
- Sovereign support for Google Cloud services/offerings in the Kingdom of Saudi Arabia, in partnership with SITE and CNTXT
- Confidential data search, enabling users to quickly search for regulated data in encrypted databases at terabyte scale
- Customer choice of deployment models: on-premises, virtual appliances running in private or public cloud, or a fully managed SaaS across multiple global regions
Fortanix Expands Client-Side Encryption to Gmail
Fortanix has added support for client-side encryption of Gmail messages, rounding out its offering as an external key manager for organizations working in the Google Workspace ecosystem. This means that data will never be sent from a knowledge worker end point such as an employee laptop without it being encrypted while in transit, boosting data privacy and security across the organization.
Fortanix now offers key management for all Google Workspace applications that use client-side encryption, including Docs, Sheets, Calendar, and now Gmail. This enables Fortanix customers who use Google Workspace to create, store, and manage encryption keys themselves, and not through Google.
Meet with Fortanix at it-sa Expo&Congress 2023
Fortanix will once again have a presence at it-sa Expo&Congress 2023, Europe's largest trade event for IT security. The event takes place Oct. 10-12 at Exhibition Centre Nuremberg in Nuremberg, Germany. Fortanix team members will be on hand in Hall 7, booth number 7-627.
For more information and to purchase tickets, visit the it-sa Expo&Congress website.
Additional Resources
- Download the Fortanix Data Security Manager brief
- Read about Fortanix client-side encryption for Google Workspace
- Explore the programming for it-sa Expo&Congress 2023
About Fortanix
Fortanix secures data, wherever it is. Fortanix’s data-first approach helps businesses of all sizes to modernize their security solutions on-premises, in the cloud, and everywhere in between. Enterprises worldwide, especially in privacy-sensitive industries like healthcare, fintech, financial services, government, and retail, trust Fortanix for data security, privacy and compliance. Fortanix investors include Goldman Sachs, Foundation Capital, Intel Capital, In-Q-Tel, Neotribe Ventures and GiantLeap Capital. Fortanix is headquartered in Santa Clara, CA. For more information, visit https://www.fortanix.com.
*Gartner, What Are the Different Provider Approaches to ‘Sovereign Cloud’ Demands?, Rene Buest, Gregor Petri, Neville Cannon, Bart Willemsen, 4 April 2022
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231010355406/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Investor Supporting Japan’s Entertainment Industry, Yoshihiro Shimamura, to Visit France Workshop to be Held During the Cannes Film Festival28.4.2026 04:00:00 CEST | Press release
Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of Hankyu Hanshin Holdings, Inc.—a major Japanese entertainment conglomerate known for producing content enjoyed across generations—and became a major shareholder (as of March 25, 2026). Through such investments, the company aims to support the global expansion of Japanese entertainment while exploring synergies with its own interna
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
